Wenjun Fu
State Key Laboratory Of Traditional Chinese Medicine Syndrome
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome.
Journal: Acta pharmaceutica Sinica. B
Published: January 09, 2025
Xiao Yao San mitigates corticosterone stimulation-induced hippocampal neuronal damage by inhibiting GR phosphorylation and nuclear translocation via FKBP4 involvement.
Journal: BMC complementary medicine and therapies
Published: November 21, 2023
Analysis of SALL1 gene variant in a boy with Townes-Brocks syndrome without anal atresia
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: April 21, 2022
The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.
Journal: Journal of gastrointestinal oncology
Published: May 20, 2021
Cyclosporine A relieved proteinuria and hypoproteinemia in DGKE nephropathy.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: January 08, 2021
COP9 Signalosome Subunit 3 Restricts Neuroinflammatory Responses During Cerebral Ischemia/Reperfusion Injury Through Stabilizing Suppressor of Cytokine Signaling 3 Protein.
Journal: Neuropsychiatric disease and treatment
Published: December 30, 2020
Xiaoyaosan (Tiaogan-Liqi therapy) protects peritoneal macrophages from corticosterone-induced stress by regulating the interaction between glucocorticoid receptor and ABCA1.
Journal: Annals of translational medicine
Published: December 14, 2020
Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.
Journal: Frontiers in cell and developmental biology
Published: July 07, 2020
Xiaoyaosan prevents atherosclerotic vulnerable plaque formation through heat shock protein/glucocorticoid receptor axis-mediated mechanism.
Journal: American journal of translational research
Published: March 13, 2019
Xiao-Yao-San reduces blood-brain barrier injury induced by chronic stress in vitro and vivo via glucocorticoid receptor-mediated upregulation of Occludin.
Journal: Journal of ethnopharmacology
Published: August 30, 2018
Senkyunolide A protects neural cells against corticosterone-induced apoptosis by modulating protein phosphatase 2A and α-synuclein signaling.
Journal: Drug design, development and therapy
Published: July 10, 2018
Last Updated: 09/26/2026